Source: BioSpace

Sensorion: Sensorion Reports Full-Year 2020 Financial Results and Provides Business Highlights

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its full-year 2020 financial results and provides an update on its business activities and outlook for 2021.

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Nawal Ouzren's photo - CEO of Sensorion

CEO

Nawal Ouzren

CEO Approval Rating

88/100

Read more